missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse VEGFR3/Flt-4 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 58 publications
Brand: R&D Systems AF743-SP
This item is not returnable.
View return policy
Description
VEGFR3/Flt-4 Polyclonal specifically detects VEGFR3/Flt-4 in Mouse samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.
Specifications
| VEGFR3/Flt-4 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| EC 2.7.10, EC 2.7.10.1, Flt-4, FLT4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4 | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 2324 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Flow Cytometry, CyTOF | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
| P35917 | |
| FLT4 | |
| S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse VEGFR3/Flt-4, Tyr25-Asp770, Accession # P35917 | |
| 25 μg | |
| Primary | |
| Detects mouse VEGFR3/Flt-4 in direct ELISAs and Western blots. In direct ELISAs, approximately 30% cross-reactivity with recombinant human (rh) VEGFR3 is observed and less than 5% cross-reactivity with recombinant mouse VEGFR2 is observed. | |
| Mouse | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction